These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 30941812)

  • 1. Estimation of average treatment effects among multiple treatment groups by using an ensemble approach.
    Yan X; Abdia Y; Datta S; Kulasekera KB; Ugiliweneza B; Boakye M; Kong M
    Stat Med; 2019 Jul; 38(15):2828-2846. PubMed ID: 30941812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Propensity scores based methods for estimating average treatment effect and average treatment effect among treated: A comparative study.
    Abdia Y; Kulasekera KB; Datta S; Boakye M; Kong M
    Biom J; 2017 Sep; 59(5):967-985. PubMed ID: 28436047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving causal inference with a doubly robust estimator that combines propensity score stratification and weighting.
    Linden A
    J Eval Clin Pract; 2017 Aug; 23(4):697-702. PubMed ID: 28116816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the performance of the generalized propensity score for estimating the effect of quantitative or continuous exposures on binary outcomes.
    Austin PC
    Stat Med; 2018 May; 37(11):1874-1894. PubMed ID: 29508424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Machine learning outcome regression improves doubly robust estimation of average causal effects.
    Choi BY; Wang CP; Gelfond J
    Pharmacoepidemiol Drug Saf; 2020 Sep; 29(9):1120-1133. PubMed ID: 32716126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Propensity score and doubly robust methods for estimating the effect of treatment on censored cost.
    Li J; Handorf E; Bekelman J; Mitra N
    Stat Med; 2016 May; 35(12):1985-99. PubMed ID: 26678242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should a propensity score model be super? The utility of ensemble procedures for causal adjustment.
    Alam S; Moodie EEM; Stephens DA
    Stat Med; 2019 Apr; 38(9):1690-1702. PubMed ID: 30586681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing approaches to causal inference for longitudinal data: inverse probability weighting versus propensity scores.
    Ertefaie A; Stephens DA
    Int J Biostat; 2010; 6(2):Article 14. PubMed ID: 21969998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The performance of different propensity score methods for estimating marginal hazard ratios.
    Austin PC
    Stat Med; 2013 Jul; 32(16):2837-49. PubMed ID: 23239115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the performance of the generalized propensity score for estimating the effect of quantitative or continuous exposures on survival or time-to-event outcomes.
    Austin PC
    Stat Methods Med Res; 2019 Aug; 28(8):2348-2367. PubMed ID: 29869566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The performance of inverse probability of treatment weighting and full matching on the propensity score in the presence of model misspecification when estimating the effect of treatment on survival outcomes.
    Austin PC; Stuart EA
    Stat Methods Med Res; 2017 Aug; 26(4):1654-1670. PubMed ID: 25934643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variance estimation for the average treatment effects on the treated and on the controls.
    Matsouaka RA; Liu Y; Zhou Y
    Stat Methods Med Res; 2023 Feb; 32(2):389-403. PubMed ID: 36476035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiply robust estimation of causal quantile treatment effects.
    Xie Y; Cotton C; Zhu Y
    Stat Med; 2020 Dec; 39(28):4238-4251. PubMed ID: 32857876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted Maximum Likelihood Estimation for Causal Inference in Observational Studies.
    Schuler MS; Rose S
    Am J Epidemiol; 2017 Jan; 185(1):65-73. PubMed ID: 27941068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stratified doubly robust estimators for the average causal effect.
    Hattori S; Henmi M
    Biometrics; 2014 Jun; 70(2):270-7. PubMed ID: 24571129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Propensity score weighting analysis and treatment effect discovery.
    Mao H; Li L; Greene T
    Stat Methods Med Res; 2019 Aug; 28(8):2439-2454. PubMed ID: 29921162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of bootstrapping when using propensity-score matching without replacement: a simulation study.
    Austin PC; Small DS
    Stat Med; 2014 Oct; 33(24):4306-19. PubMed ID: 25087884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doubly robust estimation of causal effects.
    Funk MJ; Westreich D; Wiesen C; Stürmer T; Brookhart MA; Davidian M
    Am J Epidemiol; 2011 Apr; 173(7):761-7. PubMed ID: 21385832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the use of propensity scores in case of rare exposure.
    Hajage D; Tubach F; Steg PG; Bhatt DL; De Rycke Y
    BMC Med Res Methodol; 2016 Mar; 16():38. PubMed ID: 27036963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inverse probability weighting and doubly robust standardization in the relative survival framework.
    Syriopoulou E; Rutherford MJ; Lambert PC
    Stat Med; 2021 Nov; 40(27):6069-6092. PubMed ID: 34523751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.